Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Share-based Compensation (2020 - 2025)

Candel Therapeutics' Share-based Compensation history spans 4 years, with the latest figure at $939000.0 for Q4 2023.

  • On a quarterly basis, Share-based Compensation rose 48.11% to $939000.0 in Q4 2023 year-over-year; TTM through Dec 2023 was $3.1 million, a 33.98% increase, with the full-year FY2025 number at $3.8 million, down 28.14% from a year prior.
  • Share-based Compensation hit $939000.0 in Q4 2023 for Candel Therapeutics, up from $686000.0 in the prior quarter.
  • Over the last five years, Share-based Compensation for CADL hit a ceiling of $1.9 million in Q3 2021 and a floor of -$446000.0 in Q4 2021.
  • Historically, Share-based Compensation has averaged $700000.0 across 4 years, with a median of $686000.0 in 2023.
  • The widest YoY moves for Share-based Compensation: up 2200.0% in 2021, down 125.44% in 2021.
  • Tracing CADL's Share-based Compensation over 4 years: stood at $1.8 million in 2020, then crashed by 125.44% to -$446000.0 in 2021, then surged by 242.15% to $634000.0 in 2022, then surged by 48.11% to $939000.0 in 2023.
  • Business Quant data shows Share-based Compensation for CADL at $939000.0 in Q4 2023, $686000.0 in Q3 2023, and $733000.0 in Q2 2023.